Market News: Apple is cooperating with Broadcom around artificial intelligence (AI) chips. Apple chips may be ready for production in 2026.US officials said that the United States is focused on providing Ukraine with the air defense system it needs to defend against Russian missiles and drones.Blonde Technology: Shareholders holding more than 5% of the shares plan to transfer 2% of the shares internally. Blonde Technology announced that as of the announcement date, Ms. Xiong Haitao, a shareholder, holds 122 million shares of the company, accounting for 4.64% of the company's total share capital; Ms. Xiong Haitao and her concerted actions hold a total of 216 million shares, accounting for 8.2% of the total share capital. Ms. Xiong Haitao plans to sign an agreement with Warburg Wanying Private Equity Fund to increase it as a concerted action, and plans to transfer no more than 52.73 million shares to it through block trading, that is, no more than 2% of the total share capital. After the transfer is completed, Huabao Wanying will entrust Ms. Xiong Haitao with the right to vote on the shares. This internal transfer does not involve market reduction, and the shareholding ratio remains unchanged, which does not affect the company's control.
Modern Investment: Xu Qing, the independent director of the company, was subject to disciplinary review and supervision investigation. According to the announcement of Modern Investment, Xu Qing, the independent director of the company, was suspected of serious violation of discipline and law, and is currently subject to disciplinary review by the Disciplinary Committee of Hunan Branch of Industrial and Commercial Bank of China and supervision investigation by Zhuzhou Municipal Supervision Committee. Xu Qing did not hold any other positions in the company except as an independent director, chairman of the Nomination Committee of the Board of Directors, member of the Strategy Committee of the Board of Directors and member of the Audit Committee of the Board of Directors, and did not participate in the daily operation and management of the company. The company will pay attention to the subsequent progress and fulfill its information disclosure obligations in a timely manner in strict accordance with relevant regulations.It is reported that the Bank of Japan thinks that it is no harm to raise interest rates later, but it does not rule out taking action in December. On December 11th, according to informed sources, officials of the Bank of Japan believe that it is not costly to raise interest rates later, and they are still open to taking action next week, depending on data and market trends. The authorities believe that even if the Bank of Japan decides to wait until January or later, it will not pay a huge price, because there are signs that there is little risk that inflation may exceed the target. They also said that if the December meeting proposed to raise interest rates, some officials would not object. According to people familiar with the matter, officials think it is only a matter of time to raise interest rates again, because the economy and inflation are in line with their forecasts. Before announcing the policy decision on December 19, officials will carefully evaluate the data and financial markets before making a final decision.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)
Jinfei Kaida: The controlling shareholder plans to increase the company's shares by 50 million yuan to 100 million yuan. Jinfei Kaida announced that the controlling shareholder Jinfei Holdings plans to increase the company's shares by 50 million yuan to 100 million yuan. Jinhua Branch of China Construction Bank Co., Ltd. issued the "China Construction Bank Loan Commitment Letter" to Jinfei Holdings on December 10th, promising to provide Jinfei Holdings with a special loan of no more than 90 million yuan for stock increase, with a loan period of 3 years.In 2024, the e-sports industry grew by 4.6% year-on-year, and the live broadcast revenue of e-sports content accounted for the highest proportion. On December 11th, the 2024 China E-sports Industry Annual Conference was held in Beijing. The 2024 China E-sports Industry Report was officially released at the meeting. According to the report, the actual income of e-sports industry in China in 2024 was 27.568 billion yuan, up 4.6% year-on-year. In the income composition, the live broadcast of e-sports content is still the sector with the highest proportion of income, reaching 80.84%; The income from the competition accounts for 8.75%; E-sports club income is 6.37%, and other income is 4.04%. (The country is a through train)Tesla Applied for the trademark of robot action toy, and the enterprise search app showed that Tesla Co., Ltd. recently applied for registering a trademark of "TESLA BOT ACTION FIGURE", which is classified as fitness equipment internationally. At present, the trademark status is in the process of registration application. According to media reports, recently, Tesla robot action toys were sold in official stores for 40 dollars. According to the official description, the toy is a "mini version" of Optimus Gen 2 humanoid robot, which is made in a ratio of 1:10.
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13